Retatrutide is an experimental triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors. It is being developed primarily for weight loss and metabolic disorders, including obesity and type 2 diabetes. Early clinical trials have shown significant reductions in body weight and improvements in blood sugar control. Because of its multi-receptor activity, retatrutide may have stronger effects than single-incretin therapies like semaglutide or tirzepatide. It is not yet FDA-approved or commercially available, and its long-term safety is still being evaluated.
RETA 10mg
Original price was: $115.00.$90.00Current price is: $90.00.
Product Description: Retatrutide (RETA) 10mg
Retatrutide (RETA) is a synthetic peptide that is currently under investigation in research settings for its potential role in metabolic pathways. As a multi-receptor agonist, RETA is being studied for its effects on glucose regulation, weight management, and other metabolic functions. Researchers are particularly interested in RETA’s unique binding profile and its potential applications in the study of energy balance and metabolic disorders.
This compound is provided in a 10mg vial of lyophilized powder, intended solely for laboratory research purposes.
⚠️ Full Disclaimer
-
For Research Purposes Only: This product is strictly intended for in vitro laboratory research and development.
-
Not for Human Consumption: RETA is not approved for use in humans, animals, or as a food, drug, cosmetic, or dietary supplement.
-
No Medical Claims: No statements regarding safety, efficacy, or intended use for treatment or prevention of any condition have been evaluated by Health Canada, the FDA, or any other regulatory authority.
-
Liability: The purchaser assumes full responsibility for proper handling, storage, and use of this research material in accordance with all applicable laws and regulations.
-
Storage: Store in a cool, dry place, away from direct sunlight. Proper laboratory handling procedures are required.